These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30904532)

  • 21. Analyzing the Long Time-Scale Dynamics of Uremic Toxins Bound to Sudlow Site II in Human Serum Albumin.
    Ludwig J; Smith J; Pfaendtner J
    J Phys Chem B; 2021 Mar; 125(11):2910-2920. PubMed ID: 33715376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney.
    Deguchi T; Ohtsuki S; Otagiri M; Takanaga H; Asaba H; Mori S; Terasaki T
    Kidney Int; 2002 May; 61(5):1760-8. PubMed ID: 11967025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interpretations of laboratory test data on serum protein binding].
    Takamura N; Tokunaga J; Arimori K
    Yakugaku Zasshi; 2007 Feb; 127(2):231-6. PubMed ID: 17268139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin.
    Watanabe H; Noguchi T; Miyamoto Y; Kadowaki D; Kotani S; Nakajima M; Miyamura S; Ishima Y; Otagiri M; Maruyama T
    Drug Metab Dispos; 2012 Jul; 40(7):1423-8. PubMed ID: 22513409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38.
    Katsube Y; Tsujimoto M; Koide H; Ochiai M; Hojyo A; Ogawa K; Kambara K; Torii N; Shima D; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):783-789. PubMed ID: 28314987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biophysical studies on the correction of uremic human serum albumin binding defects by in vitro charcoal adsorption treatment.
    Nikolaev V; Sarnatskaya V; von Appen K; Ivanov A; Rotellar E; Haspar M; Klinkmann H
    Artif Organs; 1996 Jan; 20(1):17-23. PubMed ID: 8645124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A; Koupparis M; Macheras P; Valsami G
    J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Domain-Specific Stabilization of Structural and Dynamic Responses of Human Serum Albumin by Sucrose.
    Mohan V; Sengupta B; Das N; Banerjee I; Sen P
    Protein Pept Lett; 2019; 26(4):287-300. PubMed ID: 30666904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of uremic toxin transport by organic anion transporters in the kidney.
    Deguchi T; Kusuhara H; Takadate A; Endou H; Otagiri M; Sugiyama Y
    Kidney Int; 2004 Jan; 65(1):162-74. PubMed ID: 14675047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin.
    Tsutsumi Y; Maruyama T; Takadate A; Goto M; Matsunaga H; Otagiri M
    Pharm Res; 1999 Jun; 16(6):916-23. PubMed ID: 10397614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of uremic serum and uremic toxins on hepatic uptake of digoxin.
    Tsujimoto M; Kinoshita Y; Hirata S; Otagiri M; Ohtani H; Sawada Y
    Ther Drug Monit; 2008 Oct; 30(5):576-82. PubMed ID: 18708994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Influence of Fatty Acids on Metoprolol - Human Serum Albumin Interaction in Low Affinity Binding Sites: A Multifactorial NMR Approach.
    Szkudlarek A; Mogielnicki M; Pentak D; Ploch A; Maciazek-Jurczyk M
    Protein Pept Lett; 2018; 25(3):285-294. PubMed ID: 29336242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A major inhibitor of phenytoin binding to serum protein in uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1988; 48(4):310-4. PubMed ID: 3362278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly sensitive simultaneous quantification of indoxyl sulfate and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high-performance liquid chromatography coupled with tandem mass spectrometry.
    Oda A; Suzuki Y; Sato B; Sato H; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
    J Sep Sci; 2022 May; 45(10):1672-1682. PubMed ID: 35247297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population.
    Snauwaert E; Holvoet E; Van Biesen W; Raes A; Glorieux G; Vande Walle J; Roels S; Vanholder R; Askiti V; Azukaitis K; Bayazit A; Canpolat N; Fischbach M; Godefroid N; Krid S; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Schaefer F; Schmitt CP; Spasojevic B; Stefanidis CJ; Van Dyck M; Van Hoeck K; Collard L; Eloot S; Shroff R
    Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 31022857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
    Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
    Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biophysical study on the interaction of an anesthetic, vecuronium bromide with human serum albumin using spectroscopic and calorimetric methods.
    Zhu Y; Zhang R; Wang Y; Ma J; Li K; Li Z
    J Photochem Photobiol B; 2014 Nov; 140():381-9. PubMed ID: 25255425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopy.
    Tramarin A; Tedesco D; Naldi M; Baldassarre M; Bertucci C; Bartolini M
    J Pharm Biomed Anal; 2019 Jan; 162():171-178. PubMed ID: 30248608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on the pharmacokinetics and redox properties of protein-bound uremic toxins.
    Watanabe H; Miyamoto Y; Otagiri M; Maruyama T
    J Pharm Sci; 2011 Sep; 100(9):3682-95. PubMed ID: 21538353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study by means of high-performance liquid chromatography of solutes that decrease theophylline/protein binding in the serum of uremic patients.
    De Smet R; Vogeleere P; Van Kaer J; Lameire N; Vanholder R
    J Chromatogr A; 1999 Jun; 847(1-2):141-53. PubMed ID: 10431358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.